ISIN | AT0000A1FNT0 |
---|---|
Valor Number | 28871817 |
Bloomberg Global ID | |
Fund Name | DSC Equity Fund – Healthcare A|A |
Fund Provider |
Dreyfus Söhne & Cie AG, Banquiers
Aeschenvorstadt 16 | Postfach 4051 Basel Schweiz Phone: +41 61 286 66 66 Web: https://www.dreyfusbank.ch |
Fund Provider | Dreyfus Söhne & Cie AG, Banquiers |
Representative in Switzerland |
Dreyfus Söhne & Cie AG, Banquiers Basel |
Distributor(s) |
Dreyfus Söhne & Cie AG, Banquiers Basel |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Austria |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 205.08 CHF | 13.05.2025 |
---|---|---|
Previous Price * | 198.79 CHF | 12.05.2025 |
52 Week High * | 246.77 CHF | 03.09.2024 |
52 Week Low * | 193.89 CHF | 22.04.2025 |
NAV * | 205.08 CHF | 13.05.2025 |
Issue Price * | 211.24 CHF | 13.05.2025 |
Redemption Price * | 205.08 CHF | 13.05.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 41,387,253 | |
Unit/Share Assets *** | 30,405,556 | |
Trading Information SIX |
YTD Performance | -8.40% |
30.12.2024 - 13.05.2025
30.12.2024 13.05.2025 |
---|---|---|
1 month | +3.13% |
14.04.2025 - 13.05.2025
14.04.2025 13.05.2025 |
3 months | -12.76% |
13.02.2025 - 13.05.2025
13.02.2025 13.05.2025 |
6 months | -11.66% |
13.11.2024 - 13.05.2025
13.11.2024 13.05.2025 |
1 year | -13.83% |
13.05.2024 - 13.05.2025
13.05.2024 13.05.2025 |
2 years | -7.95% |
15.05.2023 - 13.05.2025
15.05.2023 13.05.2025 |
3 years | -13.12% |
13.05.2022 - 13.05.2025
13.05.2022 13.05.2025 |
5 years | -4.83% |
13.05.2020 - 13.05.2025
13.05.2020 13.05.2025 |
Equity Participation Rate in % | 97.62 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 7.39% | |
---|---|---|
Johnson & Johnson | 7.14% | |
UnitedHealth Group Inc | 6.49% | |
Abbott Laboratories | 4.95% | |
AbbVie Inc | 4.60% | |
Merck & Co Inc | 4.10% | |
Sanofi SA | 3.58% | |
AstraZeneca PLC | 3.49% | |
Amgen Inc | 2.95% | |
Intuitive Surgical Inc | 2.90% | |
Last data update | 31.03.2025 |
TER | 1.53% |
---|---|
TER date | 30.04.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.52% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |